Australia · Delayed Price · Currency is AUD BLS Pharmaceuticals Statistics
Total Valuation
ASX:BLS has a market cap or net worth of AUD 277.52 million. The enterprise value is 272.66 million.
| Market Cap | 277.52M |
| Enterprise Value | 272.66M |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:BLS has 230.30 million shares outstanding. The number of shares has increased by 6.91% in one year.
| Current Share Class | 230.30M |
| Shares Outstanding | 230.30M |
| Shares Change (YoY) | +6.91% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 51.50% |
| Owned by Institutions (%) | 2.28% |
| Float | 75.35M |
Valuation Ratios
The trailing PE ratio is 17.99.
| PE Ratio | 17.99 |
| Forward PE | n/a |
| PS Ratio | 3.75 |
| PB Ratio | 8.93 |
| P/TBV Ratio | 8.96 |
| P/FCF Ratio | 172.74 |
| P/OCF Ratio | 51.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.09, with an EV/FCF ratio of 169.72.
| EV / Earnings | 17.71 |
| EV / Sales | 3.69 |
| EV / EBITDA | 13.09 |
| EV / EBIT | 13.95 |
| EV / FCF | 169.72 |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.90 |
| Quick Ratio | 1.50 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 0.40 |
| Debt / FCF | 5.25 |
| Interest Coverage | 42.49 |
Financial Efficiency
Return on equity (ROE) is 71.30% and return on invested capital (ROIC) is 45.97%.
| Return on Equity (ROE) | 71.30% |
| Return on Assets (ROA) | 34.10% |
| Return on Invested Capital (ROIC) | 45.97% |
| Return on Capital Employed (ROCE) | 51.62% |
| Weighted Average Cost of Capital (WACC) | 7.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 2.06 |
| Inventory Turnover | 3.21 |
Taxes
| Income Tax | -239,522 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +187.81% in the last 52 weeks. The beta is 0.65, so ASX:BLS's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +187.81% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 0.71 |
| Relative Strength Index (RSI) | 59.86 |
| Average Volume (20 Days) | 489,668 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:BLS had revenue of AUD 73.91 million and earned 15.40 million in profits. Earnings per share was 0.07.
| Revenue | 73.91M |
| Gross Profit | 39.48M |
| Operating Income | 19.55M |
| Pretax Income | 15.16M |
| Net Income | 15.40M |
| EBITDA | 20.13M |
| EBIT | 19.55M |
| Earnings Per Share (EPS) | 0.07 |
Balance Sheet
The company has 13.29 million in cash and 8.43 million in debt, with a net cash position of 4.86 million or 0.02 per share.
| Cash & Cash Equivalents | 13.29M |
| Total Debt | 8.43M |
| Net Cash | 4.86M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 31.09M |
| Book Value Per Share | 0.14 |
| Working Capital | 26.99M |
Cash Flow
In the last 12 months, operating cash flow was 5.41 million and capital expenditures -3.81 million, giving a free cash flow of 1.61 million.
| Operating Cash Flow | 5.41M |
| Capital Expenditures | -3.81M |
| Depreciation & Amortization | 581,314 |
| Net Borrowing | 2.32M |
| Free Cash Flow | 1.61M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 53.42%, with operating and profit margins of 26.45% and 20.83%.
| Gross Margin | 53.42% |
| Operating Margin | 26.45% |
| Pretax Margin | 20.51% |
| Profit Margin | 20.83% |
| EBITDA Margin | 27.23% |
| EBIT Margin | 26.45% |
| FCF Margin | 2.17% |
Dividends & Yields
ASX:BLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.91% |
| Shareholder Yield | -6.91% |
| Earnings Yield | 5.55% |
| FCF Yield | 0.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 24, 2026. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jun 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ASX:BLS has an Altman Z-Score of 6.71 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.71 |
| Piotroski F-Score | 4 |